The applicable margin range for LIBOR loans and the letter of credit fee ranges from 2.0% to 3.5%.
The new guidance requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP.
The Amended Credit Agreement, as amended by the Third Amendment, provides incremental facility capacity of $50 million, subject to certain conditions.
One-year performance share awards are then subject to time-based vesting pursuant to which the shares of restricted stock vest in equal annual installments over the applicable vesting period, which is generally three years.
Because our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments.
In conjunction with our acquisition of HHI in January 2016, we entered into a syndicated credit agreement (the "Previous Credit Agreement") with Regions Bank ("Regions") serving as administrative agent, which provided for a $125 million term loan facility (the "Previous Term Loan Facility") and a $50 million revolving credit facility (the "Previous Revolving Credit Facility").
The Company's unvested restricted stock awards (see Note 9) are considered participating securities under FASB Codification topic, Earnings Per Share, because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited.Our clients primarily consist of community hospitals with fewer than 200 acute care beds, with hospitals having fewer than 100 beds comprising approximately 98% of our acute care EHR client base.
We believe that our cash and cash equivalents of $4.0 million as of September 30, 2019, the future operating cash flows of the combined entity, and our remaining borrowing capacity under the Amended Revolving Credit Facility of $19.0 million as of September 30, 2019, taken together, provide adequate resources to fund ongoing cash requirements for the next twelve months.
Unlike our perpetual license arrangements under which the related revenue is recognized effectively upon installation, the SaaS arrangements result in revenue being recognized monthly as the services are provided over the term of the arrangement.
General and administrative expenses decreased 5%, or $1.9 million, as the $3.9 million in cost savings achieved through recent changes in the health benefits offered to our employees through our self-insured health plans were partially offset by increases in other expense items.
Most notably, we saw a $0.7 million decrease in non-recurring severance as a result of the one-time voluntary retirement program offered during the third quarter of 2018, which was partially offset by an $0.4 million increase in non-recurring transaction-related costs resulting from recent acquisition activity and other strategic initiatives.
A decrease in non-SaaS installation activity, along with a decrease in average contract value for the related installations, driven by smaller comparative facility sizes, resulted in non-recurring EHR revenues from new system implementations decreasing by $3.8 million from the first nine months of 2018.
On February 8, 2018, the Company entered into the Third Amendment to increase the aggregate principal amount of the Amended Credit Facilities from $162 million to $167 million, which includes the $117 million Amended Term Loan Facility and a $50 million Amended Revolving Credit Facility.
As a result, these components of working capital, which combined for $10.1 million of cash collection deferrals during the first nine months of 2018, combined to be $3.3 million cash positive during the first nine months of 2019.
Bad debt expense decreased $0.7 million compared to the third quarter of 2018 but was offset by a $0.6 million increase in employee health costs.
This decrease in non-SaaS installation activity resulted in non-recurring EHR revenues from new system implementations decreasing by $1.4 million from the third quarter of 2018.As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) pursuant to Rule 13a-15 of the Exchange Act.Item 1.Legal Proceedings.